| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/28/1999 | WO1999003973A1 Cardiac muscle regeneration using mesenchymal stem cells |
| 01/28/1999 | WO1999003878A2 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
| 01/28/1999 | WO1999003861A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 01/28/1999 | WO1999003855A1 Piperazine derivatives |
| 01/28/1999 | WO1999003854A1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 01/28/1999 | WO1999003822A1 Bicyclic metabotropic glutamate receptor ligands |
| 01/28/1999 | WO1999003817A2 Aliphatic propargylamines as cellular rescue agents |
| 01/28/1999 | WO1999003508A2 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 01/28/1999 | WO1999003498A1 USE OF FVIIa OR FVIIai FOR THE TREATMENT OF ADVERSE CONDITIONS RELATED TO THE FVIIa MEDIATED INTRACELLULAR SIGNALLING PATHWAY |
| 01/28/1999 | WO1999003473A1 Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches |
| 01/28/1999 | WO1999003469A1 Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri) |
| 01/28/1999 | WO1999003460A1 Amino acid derivatives useful to treat stroke |
| 01/28/1999 | WO1998049333A3 Eukaryotic gene expression cassette and uses thereof |
| 01/28/1999 | WO1998046632A3 Inhibitors for urokinase receptor |
| 01/28/1999 | WO1998046589A3 Indazole amide compounds as serotoninergic agents |
| 01/28/1999 | WO1998045477A3 Methods for assessing cardiovascular status and compositions for use thereof |
| 01/28/1999 | WO1998027932A3 Cerebellum and embryo specific protein |
| 01/28/1999 | DE19731571A1 Endothelin-Rezeptor-Antagonisten Endothelin receptor antagonists |
| 01/28/1999 | DE19731328A1 New 1-benzyl-imidazole and known tetrazole derivatives |
| 01/28/1999 | CA2296687A1 Piperazine derivatives |
| 01/28/1999 | CA2296468A1 Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri) |
| 01/28/1999 | CA2296310A1 Bicyclic metabotropic glutamate receptor ligands |
| 01/28/1999 | CA2294830A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 01/28/1999 | CA2237155A1 A yak-1 related serine/threonine protein kinase-htlar33 |
| 01/27/1999 | EP0893503A2 Regulator protein from Staphylococcus aureus |
| 01/27/1999 | EP0893498A2 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor |
| 01/27/1999 | EP0893493A2 Genetically modified cells and their use for prophylaxis or treatment of diseases |
| 01/27/1999 | EP0893440A1 Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it |
| 01/27/1999 | EP0892849A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 01/27/1999 | EP0892811A2 Peptides with antiproliferative properties |
| 01/27/1999 | EP0892804A1 Isoxazolidine derivatives |
| 01/27/1999 | EP0892793A1 Substituted tetracyclic tetrahydrofuran derivatives |
| 01/27/1999 | EP0892791A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 01/27/1999 | EP0892790A1 New quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having anti-hypertensive activity, a method for their preparation and their pharmaceutical use |
| 01/27/1999 | EP0892789A1 Irreversible inhibitors of tyrosine kinases |
| 01/27/1999 | EP0892788A1 Novel carboxylic acid derivatives, their production and use |
| 01/27/1999 | EP0892787A1 NOVEL $g(a)-HYDROXYLIC ACID DERIVATIVES, THEIR PRODUCTION AND USE |
| 01/27/1999 | EP0892786A1 New carboxylic acid derivatives, their production and use |
| 01/27/1999 | EP0731792B1 Heterocyclic benzenesulfonylimine derivatives as inhibitors of il-1 action |
| 01/27/1999 | CN1206422A Growth-hormone secretagogues |
| 01/27/1999 | CN1206420A Novel A1 adenosine receptor agonists and antagonists |
| 01/27/1999 | CN1206414A N-acyl-2-substituted-4-(benzimidazolyl-or imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists |
| 01/27/1999 | CN1206411A Thiol derivatives with metallopeptidase inhibitory activity |
| 01/27/1999 | CN1206348A Extracts of shark cartilage |
| 01/27/1999 | CN1206010A 5H-thiazole [3,2-a] pyrimidine derivatives |
| 01/27/1999 | CN1206005A Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors |
| 01/27/1999 | CN1041794C Stabilized pharmaceutical composition comprising an. HMG-COA reductase inhibitor compound |
| 01/26/1999 | US5864043 Cardiovascular disorders and angiotensin antagonist |
| 01/26/1999 | US5864036 Substituted imidazole compounds |
| 01/26/1999 | US5863952 Enantiomers of 1-(3,4-dichlorobenzyl)-2-methylaminoindane |
| 01/26/1999 | US5863949 Reacting carboxylic acid derivative with 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzenetriazole and hydroxylamine; treats diseases involving production of tumor necrosis factor in a mammal |
| 01/26/1999 | US5863935 Synthesis of indole derivatives of heterocyclic compounds for treatment of headaches and migraines |
| 01/26/1999 | US5863931 Amidino derivatives and their use as nitric oxide synthase inhibitors |
| 01/26/1999 | US5863930 Atherosclerosis treatment formed by reaction of pyridones with biphenylmethyl halogen |
| 01/26/1999 | US5863924 5ht2b antagonist |
| 01/26/1999 | US5863918 Naphthalene derivatives |
| 01/26/1999 | US5863917 Anxiolytic agent, anticonvulsants, analgesics and neuroprotectives. |
| 01/26/1999 | US5863916 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor |
| 01/26/1999 | US5863913 Aromatic compound and pharmaceutical composition |
| 01/26/1999 | US5863904 Methods for treating cancers and restenosis with P21 |
| 01/26/1999 | US5863890 Smooth muscle relaxants; anticoagulants; vasodilation; protein regulation; cellular metabolism; blood oxygen transport |
| 01/26/1999 | US5863766 Isolated, pure polynucleotide encoding a polypeptide for treating vesicle trafficking, immunological, and neoplastic disorders. |
| 01/26/1999 | US5863582 Washing vegetables or fruits with water treated with ion exchange resins to remove nitrate and nitrite ions, pulverizing, adding nutritional supplements |
| 01/26/1999 | CA2166901C 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
| 01/26/1999 | CA2166692C Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 01/26/1999 | CA2132829C Novel derivatives of 2,3-dihydro-benzofuranols |
| 01/26/1999 | CA2059865C Pharmaceutical compositions containing orally absorbable glycosaminoglycans |
| 01/26/1999 | CA1340332C Process for producing optically active benzene-sulfonamide derivatives |
| 01/26/1999 | CA1340329C Superoxide dismutasee |
| 01/25/1999 | CA2238664A1 Novel regulator |
| 01/25/1999 | CA2238655A1 Cdna clone my1 that encodes a novel human 7-transmembrane receptor |
| 01/23/1999 | CA2238665A1 Novel reductase |
| 01/21/1999 | WO1999002561A1 Human f11 antigen: a cell surface receptor involved in platelet aggregation |
| 01/21/1999 | WO1999002548A1 A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium |
| 01/21/1999 | WO1999002547A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 01/21/1999 | WO1999002542A1 New formulation |
| 01/21/1999 | WO1999002519A1 4,5-DIHYDRO-[1H]-BENZ[g]INDAZOLE-3-CARBOXYLIC ACID DERIVATIVES |
| 01/21/1999 | WO1999002497A2 Pyridine derivatives |
| 01/21/1999 | WO1999002172A1 PHARMACEUTICAL FORMULATIONS COMPRISING VEGETAL MATERIAL SELECTED FROM $i(TRICHILIA) |
| 01/21/1999 | WO1999002171A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 01/21/1999 | DE19730989A1 Piperazin-Derivate Piperazine derivatives |
| 01/21/1999 | CA2332636A1 Vasoprotective recombinant adenovirus vector containing a human tfpi gene |
| 01/21/1999 | CA2296037A1 4,5-dihydro-¬1h|-benz¬g|indazole-3-carboxylic acid derivatives |
| 01/21/1999 | CA2295622A1 Pharmaceutical formulations comprising vegetal material selected from trichilia |
| 01/21/1999 | CA2237698A1 Genetically modified cells and their use in the prophylaxis or therapy of disorders |
| 01/20/1999 | EP0892057A2 Response regulator |
| 01/20/1999 | EP0892052A1 Sodium-bicarbonate transporter polypeptides |
| 01/20/1999 | EP0892051A2 CDNA Clone heoad54 that encodes a human 7 transmembrane receptor |
| 01/20/1999 | EP0892049A2 A human pelota homolog |
| 01/20/1999 | EP0891978A2 5H-Thiazolo (3,2-a) pyrimidine derivatives |
| 01/20/1999 | EP0891976A1 Novel cyclic ureas useful as antiarrhythmic and antifibrillatory agents |
| 01/20/1999 | EP0891426A2 Human bikunin |
| 01/20/1999 | EP0891375A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity |
| 01/20/1999 | EP0891363A1 Heterocyclic compounds and their preparation and use |
| 01/20/1999 | EP0891362A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 01/20/1999 | EP0891361A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891360A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891357A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891356A1 Inhibitors of farnesyl-protein transferase |
| 01/20/1999 | EP0891355A1 Inhibitors of farnesyl-protein transferase |